Acelrx Pharmaceuticals (ACRX)

Acelrx (ACRX) Balance Sheet


Acelrx Balance Sheet

Acelrx's total assets for Q1 2023 were $26.29M, a decrease of -44.63% from the previous quarter. ACRX total liabilities were $10.26M for the fiscal quarter, a -60.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 47.49M$ 77.89M$ 66.30M$ 91.36M$ 120.53M
Total Liabilities
$ 25.67M$ 113.79M$ 122.05M$ 132.77M$ 116.28M
Total Equity Gross Minority
$ 28.91M$ -35.89M$ -55.75M$ -41.42M$ 4.25M
Total Capitalization
$ 36.01M$ -30.89M$ -42.61M$ -20.90M$ 7.63M
Preferred Stock Equity
Capital Lease Obligations
-$ 4.82M$ 3.72M$ 4.61M$ 0.00
Currency in USD

Acelrx Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis